PETER BARNETT: Open Payments
NPI 1013111566 · SANTA BARBARA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,792 in 60 payments from 6 companies in 2025. Trend: 2023 $1,145 · 2024 $1,386 · 2025 $1,792
Food & beverage: $1,599Education: $193
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 13 | $609 |
| E.R. Squibb & Sons, L.L.C. | 11 | $394 |
| ABBVIE INC. | 20 | $264 |
| Alkermes, Inc. | 8 | $199 |
| Otsuka America Pharmaceutical, Inc. | 6 | $172 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $152 |
Products named: COBENFY, UZEDY, VRAYLAR, ARISTADA, CAPLYTA, ABILIFY MAINTENA, REXULTI, AUSTEDO XR.
Industry payments across CA — which companies pay providers there.
